K. Aitchison

John P. Rice, P. Muglia, M. Rietschel, 2013, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Contribution of genes in the GABAergic pathway to bipolar disorder and its executive function deficit in the Chinese Han population

Xiao-hong Ma, Tao Li, K. Aitchison, 2018, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Reliability of the antipsychotic non-neurological side effects rating scale (ANNSERS)

G. Dunn, K. Aitchison, T. Barnes, 2005 .

Review and Consensus on Pharmacogenomic Testing in Psychiatry

Bahareh Behroozi Asl, F. McMahon, L. DeLisi, 2020, Pharmacopsychiatry.

Pharmacogenetics of antidepressant response: A polygenic approach. Progress in Neuro-Psychopharmacology and

Katherine, M. Rietschel, G. Breen, 2016 .

Controversial Topics in Gambling: Alberta Gambling Research Institute's 13th Annual Conference

Craig S. Chapman, A. Gruber, A. Singhal, 2014 .

Title: A functional variant in HTR7 , rs7905446, is associated with good response to SSRIs in bipolar and unipolar depression

J. Kelsoe, K. Aitchison, E. Binder, 2020 .

Cytochrome P450IID6 genotype does not determine response to clozapine

D. Collier, R. Kerwin, K. Aitchison, 1995, Schizophrenia Research.

CYP2D6 polymorphisms in Alzheimer’s disease, with and without extrapyramidal signs, showing no apolipoprotein E ε4 effect modification

S. Lovestone, J. Powell, C. Holmes, 1999, Biological Psychiatry.

THE RELEVANCE OF ETHNIC INFLUENCES ON PHARMACOGENETICS TO THE TREATMENT OF PSYCHOSIS

K. Aitchison, B. Jordan, T. Sharma, 2000, Drug metabolism and drug interactions.

Mobile App–Based Self-Report Questionnaires for the Assessment and Monitoring of Bipolar Disorder: Systematic Review

K. Aitchison, Sudhakar Sivapalan, Eric C Chan, 2021, JMIR formative research.

No association between Parkinson's disease and low-activity alleles of catechol O-methyltransferase.

D. Collier, K. Chaudhuri, K. Aitchison, 1996, Biochemical and biophysical research communications.

Stress and inflammation reduce BDNF expression in first-episode psychosis: a pathway to smaller hippocampal volume

M. D. Forti, R. Murray, C. Pariante, 2011 .

Pharmacogenetic studies of CYP2D6, CYP2C19 and CYP1A2, and investigation of their role in clinical response to antipsychotics and antidepressants

K. Aitchison, 2003 .

Failure to respond to treatment with typical antipsychotics is not associated with CYP2D6 ultrarapid hydroxylation.

R. Murray, D. Collier, P. Sham, 1999, British journal of clinical pharmacology.

Workshop outcomes report: initiatives to establish a European Network of pharmacogenetics/genomics and progress.

K. Aitchison, A. H. Maitland‐van der Zee, J. Kirchheiner, 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Clozapine pharmacokinetics and pharmacodynamics studied with CYP1A2-null mice

D. Collier, R. Kerwin, K. Aitchison, 2000, Journal of psychopharmacology.

Ecstasy, legal highs and designer drug use: A Canadian perspective

K. Aitchison, A. Hudson, K. Wells, 2014 .

Housekeeping gene expression is affected by antidepressant treatment in a mouse fibroblast cell line

K. Sugden, P. McGuffin, C. Pariante, 2010, Journal of psychopharmacology.

MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes

C. Lewis, H. Feilotter, E. Nestler, 2017, Nature Communications.

Apolipoprotein E: Depressive illness, depressive symptoms, and Alzheimer's disease

D. Collier, G. Kirov, S. Lovestone, 1998, Biological Psychiatry.

Early and delayed onset of response to antidepressants in individual trajectories of change during treatment of major depression: a secondary analysis of data from the Genome-Based Therapeutic Drugs for Depression (GENDEP) study.

M. Rietschel, A. Farmer, P. McGuffin, 2011, The Journal of clinical psychiatry.

Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-α and ribavirin treatment

M. Hotopf, C. Pariante, K. Aitchison, 2009, Molecular Psychiatry.

No association between genetic markers in BDNF gene and lithium prophylaxis in a Greek sample

A. Serretti, K. Aitchison, C. Pae, 2010, International journal of psychiatry in clinical practice.

Vasopressin and oxytocin secretion in response to the consumption of ecstasy in a clubbing population

K. Aitchison, A. Winstock, M. Forsling, 2006, Journal of psychopharmacology.

A comparative magnetic resonance spectroscopy study of GABA+ and glutamate referenced to creatine and phosphocreatine in the left dorsolateral prefrontal cortex of perimenopausal women and women of reproductive age

K. Aitchison, C. Hanstock, P. Seres, 2022, Frontiers in Psychiatry.

Single molecule long-read real-time amplicon-based sequencing of CYP2D6: a proof-of-concept with hybrid haplotypes

M. Rietschel, W. Maier, O. Mors, 2022, bioRxiv.

Measuring depression: comparison and integration of three scales in the GENDEP study

M. Rietschel, A. Elkin, A. Farmer, 2007, Psychological Medicine.

Duration of Untreated Psychosis, Referral Route, and Age of Onset in an Early Intervention in Psychosis Service and a Local CAMHS.

K. Aitchison, M. Simic, V. McAllister, 2008, Child and adolescent mental health.

Early intervention in psychosis: from Government prescription to clinical practice

K. Aitchison, F. Holloway, 2003 .

Pharmacogenetics and Psychiatry

K. Aitchison, E. Tsapakis, A. Basu, 2004, Current psychiatry reports.

Psychosocial risk factors for suicidality in children and adolescents

J. Buitelaar, J. Castro-Fornieles, K. Aitchison, 2019, European Child & Adolescent Psychiatry.

Interaction between the FTO gene, body mass index and depression: meta-analysis of 13701 individuals†

M. Rietschel, M. Gill, N. Craddock, 2017, British Journal of Psychiatry.

Epigenetic Modifications in Stress Response Genes Associated With Childhood Trauma

K. Aitchison, E. Binder, A. Cattaneo, 2019, Front. Psychiatry.

Gender differences in antidepressant drug response

K. Aitchison, R. Keers, 2010, International review of psychiatry.

Antidepressant drug-specific prediction of depression treatment outcomes from genetic and clinical variables

M. Rietschel, A. Farmer, P. McGuffin, 2018, Scientific Reports.

Pharmacogenetic studies of change in cortisol on ecstasy (MDMA) consumption

R. Kerwin, C. Pariante, K. Aitchison, 2012, Journal of psychopharmacology.

Ecstasy (MDMA)-induced hyponatraemia is associated with genetic variants in CYP2D6 and COMT

R. Kerwin, K. Aitchison, M. Forsling, 2012, Journal of psychopharmacology.

Adverse reactions to antidepressants.

Marcella Rietschel, Erik Roj Larsen, Peter McGuffin, 2009, The British journal of psychiatry : the journal of mental science.

Genome-wide association study of major recurrent depression in the U.K. population.

P. Muglia, N. Craddock, I. Craig, 2010, The American journal of psychiatry.

Familiality and SNP heritability of age at onset and episodicity in major depressive disorder

John P. Rice, M. Rietschel, M. Gill, 2015, Psychological Medicine.

University of Birmingham Familiality and SNP heritability of age at onset and episodicity in major depressive disorder

M. Rietschel, M. Gill, N. Craddock, 2015 .

Depressive disorder moderates the effect of the FTO gene on body mass index

M. Rietschel, M. Gill, N. Craddock, 2012, Molecular Psychiatry.

Pharmacogenetics of antidepressant response

K. Aitchison, R. Keers, 2011, Expert review of neurotherapeutics.

Phenotypic Association Analyses With Copy Number Variation in Recurrent Depressive Disorder

Florian Holsboer, Gerome Breen, Marcella Rietschel, 2016, Biological Psychiatry.

Effect of cytochrome CYP2C19 metabolizing activity on antidepressant response and side effects: Meta-analysis of data from genome-wide association studies

M. Rietschel, K. Tansey, I. Craig, 2018, European Neuropsychopharmacology.

Identifying the Common Genetic Basis of Antidepressant Response

M. Rietschel, W. Maier, B. Mulsant, 2021, Biological psychiatry global open science.

Antidepressants and the resilience to early-life stress in inbred mouse strains

L. Schalkwyk, E. Binder, K. Malki, 2011, Pharmacogenetics and genomics.

Development and psychometric properties of the “Suicidality: Treatment Occurring in Paediatrics (STOP) Risk and Resilience Factors Scales” in adolescents

J. Glennon, J. Buitelaar, J. Castro-Fornieles, 2019, European Child & Adolescent Psychiatry.

Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-α and ribavirin treatment

M. Hotopf, C. Pariante, K. Aitchison, 2009, Molecular Psychiatry.

The serotonin transporter is a potential susceptibility factor for bipolar affective disorder.

R. Murray, Tao Li, D. Collier, 1996, Neuroreport.

Pharmacogenomics and Psychopharmacology

K. Aitchison, Diego L Lapetina, B. Henriques, 2020, Seminars in Clinical Psychopharmacology.

How Can Drug Metabolism and Transporter Genetics Inform Psychotropic Prescribing?

K. Aitchison, Diego L Lapetina, Vasyl Yavorskyy, 2020, Frontiers in Genetics.

Investigation of blood mRNA biomarkers for suicidality in an independent sample

M. Rietschel, K. Tansey, G. Breen, 2014, Translational Psychiatry.

Genome Wide Association Analysis of Copy Number Variation in Recurrent Depressive Disorder

D. Pinto, S. Scherer, P. Muglia, 2011, Molecular Psychiatry.

White matter abnormalities and illness severity in major depressive disorder

A. Farmer, P. McGuffin, C. H. Fu, 2012, British Journal of Psychiatry.

Copy number variants and therapeutic response to antidepressant medication in major depressive disorder

T. Peters, M. Rietschel, K. Tansey, 2014, The Pharmacogenomics Journal.

Association of KIBRA rs17070145 polymorphism with episodic memory in the early stages of a human neurodevelopmental disorder

B. Puri, D. Ståhl, K. Aitchison, 2014, Psychiatry Research.

NPAS3 variants in schizophrenia: a neuroimaging study

R. Bartha, K. Aitchison, C. Hanstock, 2014, BMC Medical Genetics.

Genes associated with anhedonia: a new analysis in a large clinical trial (GENDEP)

M. Rietschel, I. Craig, G. Breen, 2018, Translational Psychiatry.

Relationship between obesity and the risk of clinically significant depression: Mendelian randomisation study

M. Rietschel, M. Gill, N. Craddock, 2014, The British journal of psychiatry : the journal of mental science.

Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: The role of stress and of antipsychotic treatment

R. Murray, C. Pariante, K. Aitchison, 2010, Schizophrenia Research.

Neurological Structure Variations in Individuals with Autism Spectrum Disorder: a Review

K. Aitchison, Sudhakar Sivapalan, 2014 .

Allelic association between a Ser-9-Gly polymorphism in the dopamine D3 receptor gene and schizophrenia

D. Collier, P. Sham, D. Ball, 1996, Human Genetics.

Costs and outcomes associated with an aripiprazole add-on or switching open-label study in psychosis

K. Aitchison, P. McCrone, V. O’Keane, 2011, Journal of psychopharmacology.

Higher cortisol levels are associated with smaller left hippocampal volume in first-episode psychosis

Robin M. Murray, Marta Di Forti, Alessandro D'Albenzio, 2010, Schizophrenia Research.

Candidate Genes Expression Profile Associated with Antidepressants Response in the GENDEP Study: Differentiating between Baseline ‘Predictors' and Longitudinal ‘Targets'

I. Craig, G. Breen, A. Farmer, 2012, Neuropsychopharmacology.

Candidate Genes Expression Profile Associated with Antidepressants Response in the GENDEP Study: Differentiating between Baseline ‘Predictors’ and Longitudinal ‘Targets’

I. Craig, G. Breen, A. Farmer, 2013, Neuropsychopharmacology.

Childhood and later life stressors and psychosis

K. Aitchison, S. Purdon, L. Roper, 2015 .

Genome-wide association study of increasing suicidal ideation during antidepressant treatment in the GENDEP project

M. Rietschel, I. Craig, G. Breen, 2010, The Pharmacogenomics Journal.

Genomewide Association Scan of Suicidal Thoughts and Behaviour in Major Depression

Bertram Müller-Myhsok, Gerome Breen, Michael Gill, 2011, PloS one.

Dimensions of temperament and character as predictors of antidepressant discontinuation, response and adverse reactions during treatment with nortriptyline and escitalopram.

M. Rietschel, A. Farmer, P. McGuffin, 2021, Psychological medicine.

Exploring the role of drug-metabolising enzymes in antidepressant side effects

M. Rietschel, K. Tansey, I. Craig, 2015, Psychopharmacology.

Genetic predictors of antidepressant side effects: A grouped candidate gene approach in the Genome-Based Therapeutic Drugs for Depression (GENDEP) study

M. Rietschel, A. Farmer, P. McGuffin, 2014, Journal of psychopharmacology.

Genome-Based Therapeutic Drugs for Depression ( GENDEP ) study Genetic predictors of antidepressant side effects : A grouped candidate gene approach in the

M. Rietschel, A. Farmer, P. McGuffin, 2014 .

Genetic Predictors of Response to Serotonergic and Noradrenergic Antidepressants in Major Depressive Disorder: A Genome-Wide Analysis of Individual-Level Data and a Meta-Analysis

T. Peters, M. Rietschel, K. Tansey, 2012, PLoS medicine.

Variation in GNB3 predicts response and adverse reactions to antidepressants

M. Rietschel, I. Craig, A. Elkin, 2011, Journal of psychopharmacology.

Changes in body weight during pharmacological treatment of depression.

M. Rietschel, A. Farmer, P. McGuffin, 2011, International Journal of Neuropsychopharmacology.

Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: Clinical description and the role of the 5-HTTLPR

M. Rietschel, A. Farmer, P. McGuffin, 2011, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Moderation of antidepressant response by the serotonin transporter gene

M. Rietschel, I. Craig, A. Farmer, 2009, British Journal of Psychiatry.

Modulation of amygdala response and connectivity in depression by serotonin transporter polymorphism and diagnosis.

A. Farmer, P. McGuffin, S. Costafreda, 2013, Journal of affective disorders.

Interaction between serotonin transporter gene variants and life events predicts response to antidepressants in the GENDEP project

M. Rietschel, I. Craig, A. Farmer, 2011, The Pharmacogenomics Journal.

Tumor necrosis factor and its targets in the inflammatory cytokine pathway are identified as putative transcriptomic biomarkers for escitalopram response

A. Danese, K. Tansey, I. Craig, 2013, European Neuropsychopharmacology.

Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms

M. Rietschel, A. Farmer, P. McGuffin, 2011, Psychological Medicine.

Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline.

M. Rietschel, A. Farmer, P. McGuffin, 2011, Journal of affective disorders.

Genome-wide pharmacogenetics of antidepressant response in the GENDEP project.

P. Muglia, M. Rietschel, T. Schulze, 2010, The American journal of psychiatry.

Genetic predictors of response to antidepressants in the GENDEP project

Thomas G Schulze, Marcella Rietschel, Erik Roj Larsen, 2009, The Pharmacogenomics Journal.

Association study of dopamine receptor gene polymorphisms with drug-induced hallucinations in patients with idiopathic Parkinson's disease.

K. Aitchison, M. Arranz, R. Grünewald, 2000, Pharmacogenetics.

The genetics of depression and related traits

K. Aitchison, P. Huezo-Diaz, K. Tandon, 2005, Current psychiatry reports.

No evidence for an association of affective disorders with high- or low-activity allele of catechol-o-methyltransferase gene

Robin M. Murray, Michael Gill, David A. Collier, 1997, Biological Psychiatry.

Psychiatry and the ‘new genetics’: hunting for genes for behaviour and drug response

I. Craig, P. McGuffin, K. Aitchison, 2005, British Journal of Psychiatry.

Interplay between Schizophrenia Polygenic Risk Score and Childhood Adversity in First-Presentation Psychotic Disorder: A Pilot Study

R. Murray, E. Vassos, P. Sham, 2016, PloS one.

Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.

Stephan Ripke, Steven P. Hamilton, Florian Holsboer, 2013, The American journal of psychiatry.

Stressful life events, cognitive symptoms of depression and response to antidepressants in GENDEP.

M. Rietschel, T. Schulze, A. Farmer, 2010, Journal of affective disorders.

Convergent Animal and Human Evidence Suggests a Role of PPM1A Gene in Response to Antidepressants

M. Rietschel, I. Craig, A. Farmer, 2011, Biological Psychiatry.

History of suicide attempts among patients with depression in the GENDEP project.

M. Rietschel, A. Farmer, P. McGuffin, 2010, Journal of affective disorders.

Suicidal ideation during treatment of depression with escitalopram and nortriptyline in Genome-Based Therapeutic Drugs for Depression (GENDEP): a clinical trial

M. Rietschel, A. Elkin, A. Farmer, 2009, BMC medicine.

Pharmacogenetics in the postgenomic era.

K. Aitchison, M. Gill, 2003 .

Pharmacogenetic Testing Options Relevant to Psychiatry in Canada: Options de tests pharmacogénétiques pertinents en psychiatrie au Canada

K. Aitchison, P. Arnold, D. Müller, 2020, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Pharmacogenetics of antidepressant response: A polygenic approach

T. Peters, M. Rietschel, T. Schulze, 2016, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Body weight as a predictor of antidepressant efficacy in the GENDEP project.

M. Rietschel, A. Farmer, P. McGuffin, 2009, Journal of affective disorders.

A functional variant in the serotonin receptor 7 gene (HTR7), rs7905446, is associated with good response to SSRIs in bipolar and unipolar depression

M. Rietschel, J. Kelsoe, O. Mors, 2019, Molecular Psychiatry.

Effect of antidepressant switching between nortriptyline and escitalopram after a failed first antidepressant treatment among patients with major depressive disorder

M. Rietschel, A. Farmer, P. McGuffin, 2019, British Journal of Psychiatry.

Association between C-reactive protein (CRP) with depression symptom severity and specific depressive symptoms in major depression

M. Rietschel, K. Tansey, A. Farmer, 2017, Brain, Behavior, and Immunity.

Dissecting the Genetic Heterogeneity of Depression Through Age at Onset

John P. Rice, P. Muglia, M. Rietschel, 2012, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Pharmacogenetics in Psychiatry

K. Aitchison, N. Vyas, A. Daly, 2012 .

Trajectories of change in depression severity during treatment with antidepressants

M. Rietschel, A. Farmer, P. McGuffin, 2009, Psychological Medicine.

Genetic Predictors of Increase in Suicidal Ideation During Antidepressant Treatment in the GENDEP Project

M. Rietschel, T. Schulze, I. Craig, 2009, Neuropsychopharmacology.

Transcriptomics and the mechanisms of antidepressant efficacy

M. Rietschel, K. Tansey, I. Craig, 2016, European Neuropsychopharmacology.

Extracting a needle from a haystack: reanalysis of whole genome data reveals a readily translatable finding

A. Farmer, K. Aitchison, R. Keers, 2009, Psychological Medicine.

Methodology for clinical genotyping of CYP2D6 and CYP2C19

M. Rietschel, W. Maier, O. Mors, 2021, Translational Psychiatry.

Cross-validation of technologies for genotyping CYP2D6 and CYP2C19

Bahareh Behroozi Asl, M. Rietschel, W. Maier, 2019, bioRxiv.

Regional distribution of clomipramine and desmethylclomipramine in rat brain and peripheral organs on chronic clomipramine administration

K. Aitchison, D. Dexter, K. Datla, 2010, Journal of psychopharmacology.

Change in sexual dysfunction with aripiprazole: a switching or add-on study

R. Williamson, K. Aitchison, V. O’Keane, 2008, Journal of psychopharmacology.

Sequence2Script: A Web-Based Tool for Translation of Pharmacogenetic Data Into Evidence-Based Prescribing Recommendations

K. Aitchison, C. Bousman, Patrick Wu, 2021, Frontiers in Pharmacology.

Weight Gain and Other Metabolic Adverse Effects Associated with Atypical Antipsychotic Treatment of Children and Adolescents: A Systematic Review and Meta-analysis

K. Aitchison, F. Besag, I. Wong, 2013, Pediatric Drugs.

Haplotype phasing of CYP2D6: an allelic ratio method using Agena MassARRAY data

K. Aitchison, Cheryl A. Mather, Megana Thamilselvan, 2023, bioRxiv.

The genetics of affective disorder and suicide

I. Craig, P. McGuffin, C. Lewis, 2010, European Psychiatry.

Reduced Anxiety and Depression-Like Behaviours in the Circadian Period Mutant Mouse Afterhours

S. Cichon, M. Rietschel, M. Nöthen, 2012, PloS one.

The effect of age on DNA concentration from whole saliva: Implications for the standard isolation method

J. Castro-Fornieles, K. Aitchison, P. Santosh, 2014, American journal of human biology : the official journal of the Human Biology Council.

Differential gene expression analysis in blood of first episode psychosis patients

R. Murray, G. Breen, R. Dobson, 2019, Schizophrenia Research.

New insights on the pharmacogenomics of antidepressant response from the GENDEP and STAR*D studies: rare variant analysis and high-density imputation

M. Rietschel, K. Tansey, G. Breen, 2017, bioRxiv.

Effects of antidepressant drug exposure on gene expression in the developing cerebral cortex

K. Sugden, F. Tarazi, K. Aitchison, 2014, Synapse.

Genetic differences in cytochrome P450 enzymes and antidepressant treatment response

M. Rietschel, K. Tansey, I. Craig, 2014, Journal of psychopharmacology.

Implications of Cannabis Legalization on Youth and Young Adults

R. Lam, J. Sareen, K. Aitchison, 2018, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Serum and gene expression profile of cytokines in first-episode psychosis

R. Murray, C. Pariante, K. Aitchison, 2013, Brain, Behavior, and Immunity.

Prediction and Understanding of Resilience in Albertan Families: Longitudinal Study of Disaster Responses (PURLS) – Protocol

K. Aitchison, P. Arnold, K. Wynne-Edwards, 2019, Front. Psychiatry.

Decreased Medial Prefrontal Cortex Glutamate Levels in Perimenopausal Women

K. Aitchison, C. Hanstock, P. Seres, 2021, Frontiers in Psychiatry.

Ethnic variations in pathways into early intervention services for psychosis

K. Aitchison, H. Fisher, L. Hobbs, 2013, British Journal of Psychiatry.

CYP2D6 and Antipsychotic Treatment Outcomes in Children and Youth: A Systematic Review.

K. Aitchison, P. Arnold, D. Müller, 2020, Journal of child and adolescent psychopharmacology.

Identification of high-impact gene-drug pairs for pharmacogenetic testing in Alberta, Canada.

K. Aitchison, Stacey Hume, C. Bousman, 2020, Pharmacogenetics and genomics.

Interplay between Schizophrenia Polygenic Risk Score and Childhood Adversity in First-Presentation Psychotic Disorder: A Pilot Study

E. Vassos, P. Sham, S. Cherny, 2016, PLoS ONE.

Pharmacogenetics: antidepressant drug response

K. Aitchison, A. Basu, 2005 .

Identification of novel polymorphisms in the 5' flanking region of CYP1A2, characterization of interethnic variability, and investigation of their functional significance.

D. Collier, R. Kerwin, K. Aitchison, 2000, Pharmacogenetics.

Potential therapeutic benefits of cannabinoid products in adult psychiatric disorders: A systematic review and meta-analysis of randomised controlled trials.

R. Lam, K. Aitchison, P. Tibbo, 2021, Journal of psychiatric research.

Are There Therapeutic Benefits of Cannabinoid Products in Adult Mental Illness?

R. Lam, K. Aitchison, P. Tibbo, 2020, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Duration of untreated psychosis in adolescents: Ethnic differences and clinical profiles

K. Aitchison, J. Woolley, H. Fisher, 2013, Schizophrenia Research.

THE SEARCHFORGENES INFLUENCINGBEHAVIOUR

I. Craig, P. McGuffin, K. Aitchison, 2004 .

Interaction Between Functional Genetic Variation of DRD2 and Cannabis Use on Risk of Psychosis.

R. Murray, A. David, J. Powell, 2015, Schizophrenia bulletin.

Haplotype phasing of CYP2D6: an allelic ratio method using Agena MassARRAY data

K. Aitchison, Yabing Wang, Cheryl A. Mather, 2023, bioRxiv.

The Dutch GROUP study

J. Waddington, P. Scully, K. Aitchison, 2006 .

Associations between the LEP -2548G/A Promoter and Baseline Weight and between LEPR Gln223Arg and Lys656Asn Variants and Change in BMI z Scores in Arab Children and Adolescents Treated with Risperidone

K. Aitchison, C. Slomp, F. Besag, 2018, Molecular Neuropsychiatry.

P.2.d.007 Proteomic analysis of hippocampus and frontal cortex in a rat model of depression with gene-environment interaction and antidepressant treatment

K. Aitchison, E. Domenici, L. Carboni, 2006, European Neuropsychopharmacology.

Title Genomewide association scan of suicidal thoughts andbehaviour in major depression

P. Muglia, M. Rietschel, M. Gill, 2011 .

133. Interplay Between Schizophrenia Polygenic Risk Score and Childhood Adversity in First-presentation Psychotic Disorder: A Pilot Study

R. Murray, E. Vassos, P. Sham, 2017 .

Modulatory effects of brain-derived neurotrophic factor Val66Met polymorphism on prefrontal regions in major depressive disorder

A. Farmer, P. McGuffin, S. Costafreda, 2015, British Journal of Psychiatry.

Validation of Single Nucleotide Variant Assays for Human Leukocyte Antigen Haplotypes HLA-B*15:02 and HLA-A*31:01 Across Diverse Ancestral Backgrounds

Xiu-ying Hu, K. Aitchison, Amanda Buchner, 2021, Frontiers in Pharmacology.

Routine evaluation in first episode psychosis services: feasibility and results from the MiData project

K. Aitchison, T. Craig, H. Fisher, 2008, Social Psychiatry and Psychiatric Epidemiology.

Assessing 42 inflammatory markers in 321 control subjects and 887 major depressive disorder cases: BMI and other confounders and overall predictive ability for current depression

M. Rietschel, D. Collier, M. Hotopf, 2018, bioRxiv.

Changes in biomarkers of bone turnover in an aripiprazole add-on or switching study

K. Aitchison, A. Heald, R. Sherwood, 2016, Schizophrenia Research.

Cost-effectiveness of clozapine

R. Kerwin, K. Aitchison, 1997, British Journal of Psychiatry.

Cost-effectiveness of clozapine

R. Kerwin, K. Aitchison, 1997, British Journal of Psychiatry.

Aripiprazole in psychotic depression: Four case reports

K. Aitchison, V. O’Keane, V. McAllister, 2006 .

CYP2C19 genotype predicts steady state escitalopram concentration in GENDEP

M. Rietschel, I. Craig, A. Farmer, 2012, Journal of psychopharmacology.

Reply to Dawes et al.

K. Aitchison, P. Arnold, D. Müller, 2020, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Decreased GABA+ Levels in the Medial Prefrontal Cortex of Perimenopausal Women: A 3T 1H-MRS Study

K. Aitchison, C. Hanstock, P. Seres, 2022, The international journal of neuropsychopharmacology.

A UK consensus on the administration of aripiprazole for the treatment of mania

G. Goodwin, G. Goodwin, K. Aitchison, 2009, Journal of psychopharmacology.

Mobile App–Based Self-Report Questionnaires for the Assessment and Monitoring of Bipolar Disorder: Systematic Review (Preprint)

K. Aitchison, Sudhakar Sivapalan, Yuting Sun, 2019 .

Exploring the role of drug-metabolising enzymes in antidepressant side effects

M. Rietschel, K. Tansey, I. Craig, 2015, Psychopharmacology.

Trend level gene-gender interaction effect for the BDNF rs6265 variant on age of onset of psychosis

K. Aitchison, S. Purdon, P. Tibbo, 2019, Psychiatry Research.

Single molecule long-read real-time amplicon-based sequencing of CYP2D6: a proof-of-concept with hybrid haplotypes

M. Rietschel, W. Maier, O. Mors, 2023, bioRxiv.

Genetic Predictors of Increase in Suicidal Ideation During Antidepressant Treatment in the GENDEP Project

M. Rietschel, T. Schulze, I. Craig, 2009, Neuropsychopharmacology.

Can genetics inform the management of cognitive deficits in schizophrenia?

A. Malhotra, V. Kumari, K. Aitchison, 2012, Journal of psychopharmacology.

Genome-wide association study of major recurrent depression in the U.K. population.

P. Muglia, N. Craddock, I. Craig, 2010, The American journal of psychiatry.

Depressive disorder moderates the effect of the FTO gene on body mass index

M. Rietschel, M. Gill, N. Craddock, 2012, Molecular Psychiatry.

Ethnic variations in pathways into early intervention services for psychosis

K. Aitchison, H. Fisher, L. Hobbs, 2013, British Journal of Psychiatry.

Decreased GABA+ ratios referenced to creatine and phosphocreatine in the left dorsolateral prefrontal cortex of females of reproductive age with major depression

K. Aitchison, C. Hanstock, P. Seres, 2023, Journal of psychiatry & neuroscience : JPN.

Genetic disposition to inflammation and response to antidepressants in major depressive disorder.

M. Rietschel, A. Farmer, P. McGuffin, 2018, Journal of psychiatric research.

Effect of cytochrome CYP2C19 metabolizing activity on antidepressant response and side effects: Meta-analysis of data from genome-wide association studies

M. Rietschel, K. Tansey, I. Craig, 2018, European Neuropsychopharmacology.

New insights into the pharmacogenomics of antidepressant response from the GENDEP and STAR*D studies: rare variant analysis and high-density imputation

M. Rietschel, K. Tansey, G. Breen, 2017, The Pharmacogenomics Journal.

Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: The role of stress and of antipsychotic treatment

C. Pariante, K. Aitchison, V. Mondelli, 2010, Schizophrenia Research.

Development and psychometric properties of the Suicidality: Treatment Occurring in Paediatrics (STOP) Suicidality Assessment Scale (STOP-SAS) in children and adolescents

J. Glennon, J. Buitelaar, J. Castro-Fornieles, 2016, BMC Pediatrics.

Internal consistency and concurrent validity of self-report components of a new instrument for the assessment of suicidality, the Suicide Ideation and Behavior Assessment Tool (SIBAT)

K. Aitchison, P. Carnes, B. Green, 2021, Psychiatry Research.

Modulation of amygdala response and connectivity in depression by serotonin transporter polymorphism and diagnosis.

A. Farmer, P. McGuffin, S. Costafreda, 2013, Journal of affective disorders.

Cost-effectiveness of clozapine

R. Kerwin, K. Aitchison, 1997, British Journal of Psychiatry.

Meta-analysis of CYP2C19 and CYP2D6 metabolic activity on antidepressant response from 13 clinical studies using genotype imputation

M. Rietschel, R. Weinshilboum, A. McIntosh, 2023, medRxiv.